Clinical trial
To Evaluate Bacteriophage OX174 Antigen as a Useful Immunogen in Patients With Immune Deficiency
NCT01617122 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- To Evaluate Bacteriophage OX174 Antigen as a Useful Immunogen in Patients With Immune Deficiency
- Lead sponsor
- University of South Florida
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 31, 1995
- Completion date
- December 31, 2015
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
primary immune deficiency diseases